1-3 of 3
Qiang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular Carcinoma

Jianing Ma, Yuning Xin, Qiang Wang, Lijuan Ding
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (4): 447–453.
https://doi.org/10.1158/1535-7163.MCT-23-0373
Published: 02 April 2024
View article titled, Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular Carcinoma
Open the PDF for Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular Carcinoma in another window
Journal Articles

Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model

Mandy Berndt-Paetz, Philipp Schulze, Philipp C. Stenglein, Annett Weimann, Qiang Wang, Lars-Christian Horn, Yasser M. Riyad, Jan Griebel, Ralf Hermann, Annegret Glasow, Jens-Uwe Stolzenburg, Jochen Neuhaus
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (4): 743–750.
https://doi.org/10.1158/1535-7163.MCT-18-1194
Published: 01 April 2019
View article titled, Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model
Open the PDF for Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model in another window
Includes: Supplementary data
Journal Articles

Abstract B194: Tivantinib in combination with erlotinib vs erlotinib alone for EGFR mutant NSCLC: Subgroup results from the phase 3 MARQUEE study

Giorgio V. Scagliotti, Sergey Orlov, Joachim von Pawel, Frances A. Shepherd, Wallace Akerley, Jeffrey S. Ross, Dale Shuster, Qiang Wang, Brian Schwartz, Reinhard von Roemeling
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): B194.
https://doi.org/10.1158/1535-7163.TARG-15-B194
Published: 01 December 2015
View article titled, Abstract B194: Tivantinib in combination with erlotinib vs erlotinib alone for EGFR mutant NSCLC: Subgroup results from the phase 3 MARQUEE study